Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

Completed · Phase 2

Conditions studied: Eye Diseases

In brief

The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.

Key facts

Study ID

NCT00315640

Run by

Alcon Research

People needed

70

Starts

2005-12-01

Expected to finish

2009-07-01

Last updated by the study team

2012-11-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Either gender
• 18 years of age or older
• IOP elevation caused by steroid usage
• Other protocol-defined inclusion criteria may apply

You may not qualify if…

• Under 18 years of age
• Other protocol-defined exclusion criteria may apply

Where it is running

• Jacksonville — Jacksonville, Florida, United States
• Miami — Miami, Florida, United States
• Detroit — Detroit, Michigan, United States
• Study site — Fort Worth, Texas, United States
• Houston — Houston, Texas, United States
• San Paulo — São Paulo, Brazil
• Budapest — Budapest, Hungary
• Padova — Padova, Italy
• Amsterdam — Amsterdam, Netherlands
• Bayamon — Bayamón, Puerto Rico
• Barcelona — Barcelona, Spain
• Newcastle upon Tyne — Newcastle upon Tyne, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.